Xencor Inc. to Present at TD Cowen Immunology and Inflammation Virtual Summit
Xencor Inc., a clinical-stage biopharmaceutical company, will present at the TD Cowen Immunology and Inflammation Virtual Summit on November 12, 2025, at 3:00 p.m. ET. This event will showcase the company's developments in engineered antibodies for cancer and autoimmune diseases. The information is generated by Public Technologies and should not be considered financial or legal advice.
Xencor Inc., a clinical-stage biopharmaceutical company developing engineered antibodies for cancer and autoimmune diseases, will participate in the TD Cowen Immunology and Inflammation Virtual Summit on November 12, 2025. The company’s management is scheduled to present at 3:00 p.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xencor Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251110946225) on November 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
